QualityStocks would like to highlight Bovie Medical Corporation (NYSE AMEX: BVX). The company is actively engaged in the business of manufacturing and marketing a variety of electrosurgical medical products, as well as developing related technologies and products. Recently, greater effort and resources have been directed towards manufacturing electrosurgical generators which are primarily used for outpatient surgical procedures. Bovie continues the ongoing development of high-powered generators for operating room use. It is estimated that the electrosurgery industry is currently growing 10% annually and is used in 80% of all surgical procedures performed worldwide.
In the
company’s news yesterday,
J-Plasma(TM) is formed by passing an inert gas, such as helium, over a sharp conductive point which is held at high voltage and high frequency, producing a luminous discharge beam. The sharp conductive point can also be in the form of a retractable surgical blade, providing multiple modes of operation in a single instrument. The extended surgical blade can be used for incisions and other cutting procedures, and when retracted, the blade is used to form the J-Plasma beam for coagulation. The extended blade can also be used in combination with the J-Plasma beam, providing an enhanced cutting capability with minimal impact on surrounding tissue.
The company,
assisted by leading surgeons, will introduce J-Plasma(TM) at selected hospital
beta sites including several university teaching facilities, in preparation for
a market launch later this year by its independent sales distribution network.
Bovie Medical Corporation CEO Andrew Makrides commented, "This is a significant development toward Bovie becoming a leader in plasma surgery and achieving increased prominence in the electrosurgery marketplace."
Bovie
recently announced the granting of a United States patent for a "Method to
generate a plasma stream for performing electrosurgery", adding to the
Company's J-Plasma(TM) patent portfolio. Bovie has four patents related to its
J-Plasma(TM) technology with three additional patent applications pending.
About
QualityStocks:
QualityStocks,
based in Scottsdale, Arizona, is a free service that collects data from
hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one
Daily Newsletter Report. QualityStocks is dedicated to assisting emerging
public companies with their investor communication efforts and connecting
subscribers with companies that have huge potential to succeed in the short and
long-term future.
To sign up
for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net
Forward-Looking Statement:
This release
may contain forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended. All forward-looking statements are inherently
uncertain as they are based on current expectations and assumptions concerning
future events or future performance of the company. Readers are cautioned not
to place undue reliance on these forward-looking statements, which are only
predictions and speak only as of the date hereof. Risks and uncertainties
applicable to the company and its business could cause the company's actual
results to differ materially from those indicated in any forward-looking
statements.
